Research opportunities in prevention and population research
We support a broad portfolio of prevention and population research aimed at understanding the epidemiology of cancer, cancer risk, incidence and survival and preventative interventions.
Our research strategy is driven by patient and public benefit, and we aim to fund research that has the potential for practical impact on clinical practice or public policy.
We fund investigator-led projects, partnership initiatives and invest in research facilities and resources. We're also committed to supporting the next generation of cancer researchers, and have a range of opportunities to help you develop your research career or apply your population research expertise to cancer for the first time.
We have a number of grants available, whether you're looking for programme funding for your research group or grants for specific projects.
|Prevention and Population Research Programme Award
Provides long-term support for broad, multidisciplinary research with transformative potential in prevention and population research.
|Prevention and Population Research Project Award
Provide support for focused research proposals centred on key questions in prevention and population research.
Enables translational research by funding cross-institutional teams to produce tools, platforms and resources which will transform the research landscape.
Opportunities for early-career researchers
We're committed to supporting the next generation of cancer researchers, and we have a range of opportunities for students, post-docs and early- and mid-career group leaders, from studentships and fellowships to training and travel grants.
We fund the best research from the best researchers, across the spectrum of population research related to cancer. We focus our portfolio on research which has the potential to make a practical impact on clinical practice or public policy for patient and public benefit.
You can find out who we have recently funded, or browse the case studies below for a taste of the kinds of projects and programmes that we support.
Richard Martin, Professor of Clinical Epidemiology and leader of the CRUK-funded CAP trial of prostate cancer screening, talked to us about the impact of the study and the advice he’d give researchers seeking funding for population research.
We've launched an international collaboration to answer the final questions before aspirin could be recommended to reduce cancer risk, funded by our Catalyst Award.
We caught up with Willie Hamilton and Fiona Walter to find out why, with appropriate safeguards, making patient data accessible for research is so important for beating cancer sooner.
We believe earlier detection and diagnosis of cancer offers the greatest potential for transformational improvements in patient outcomes, and we have a range of opportunities in this field.
We support a broad portfolio of clinical and translational research through response mode funding, initiatives and investments in clinical infrastructure.
Our ambition is to accelerate progress to see 3 in 4 people with cancer surviving the disease by 2034. Our Research Strategy outlines how we will achieve our objectives through a substantial increase in research in priority areas.